AK

Akhilesh Kumar Srivastava

Active Director Director DIN 10568002
DIN 10568002 First appointment Mar 2024 Primary industry Professional Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Akhilesh Kumar Srivastava

Data last updated:

Akhilesh Kumar Srivastava is a Director at C-Mune Therapeutics Private Limited (since 2024). The company operates in Professional Services.

DIN 10568002
Primary Designation Director
Industry Professional Services
First Appointment 28 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
C-Mune Therapeutics Private Limited U72100TS2024PTC183840
Director28 Mar 20242024Active

Board colleagues of Akhilesh Kumar Srivastava

NameDINCompanyDesignation
Vijay Kumar Raina09759349C-Mune Therapeutics Private LimitedDirector

Directorship timeline

Open interactive timeline →
C-Mune Therapeutics Private Limited
Premium access

Shareholding and investment profile for Akhilesh Kumar Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akhilesh Kumar Srivastava

Akhilesh Kumar Srivastava currently holds 1 directorship: C-Mune Therapeutics Private Limited (Director, since 28 Mar 2024).

Akhilesh Kumar Srivastava was first appointed on 28 Mar 2024 as Director at C-Mune Therapeutics Private Limited.

The current boards of Akhilesh Kumar Srivastava's companies include Vijay Kumar Raina (C-Mune Therapeutics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available